US 7189513
Human papilloma virus immunoreactive peptides
granted A61KA61K2039/57A61K2039/6006
Quick answer
US patent 7189513 (Human papilloma virus immunoreactive peptides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/57, A61K2039/6006, A61K39/00, A61P